Tfr cells lack IL-2Rα but express decoy IL-1R2 and IL-1Ra and suppress the IL-1–dependent activation of Tfh cells

See allHide authors and affiliations

Science Immunology  08 Sep 2017:
Vol. 2, Issue 15, eaan0368
DOI: 10.1126/sciimmunol.aan0368

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Immune regulation in the germinal center

Unregulated production of antibodies may contribute to the development of autoimmunity. Follicular regulatory T (Tfr) cells are thought to limit the germinal center (GC) reaction and to reduce antibody production within B cell follicles in both humans and mice, yet how Tfr cells control the GC reaction remains unclear. Ritvo et al. closely characterize Tfr cells and identify these cells as a rare population of CD4+CXCR5+PD-1+Foxp3+ cells that do not express CD25 and do not respond to interleukin-2. When compared with follicular helper T (Tfh) cells and regulatory T cells, Tfr cells clustered with Tfh cells. Moreover, they expressed decoy molecules for the interleukin-1 signaling pathway, suggesting a mechanism for the suppression of Tfh cells.


Follicular regulatory T (Tfr) cells from lymph node germinal centers control follicular helper T (Tfh) cell–dependent B cell activation. These scarce cells, often described and purified as CD25+ cells, are thought to be derived from thymic regulatory T (Treg) cells. However, we observed that mouse Tfr cells do not respond to interleukin-2 (IL-2), unlike Treg cells. Stringent immunophenotyping based on B cell lymphoma 6 (Bcl6), programmed cell death protein 1 (PD-1), and CXCR5 expression revealed that Tfr cells are actually CD25, in mice and humans. Moreover, Tfr cell characterization based only on CXCR5 and PD-1 high expression without excluding CD25+ cells resulted in contamination with Treg cells. Transcriptome studies of CD4+CXCR5+PD-1+Bcl6+Foxp3+CD25 Tfr cells revealed that they express the IL-1 decoy receptor IL-1R2 and the IL-1 receptor antagonist IL-1Ra, whereas Tfh cells express the IL-1R1 agonist receptor. IL-1 treatment expanded Tfh cells in vivo and activated their production of IL-4 and IL-21 in vitro. Tfr cells suppressed the IL-1–induced activation of Tfh cells as efficiently as the IL-1 receptor antagonist Anakinra. Altogether, these results reveal an IL-1 axis in the Tfh cell control of B cell responses and an IL-2/IL-1 dichotomy for Treg cell control of effector T cells versus Tfr cell control of Tfh cells.

View Full Text